Prognostic Impact of Atrial Rhythm and Dimension in Patients with Structural Heart Disease Undergoing Cardiac Sympathetic Denervation for Ventricular Arrhythmias.
Cardiac sympathetic denervation (CSD) is a promising treatment for patients with structural heart disease (SHD) and refractory ventricular tachyarrhythmias (VT). The effect of CSD on atrial rhythm, as well as the prognostic impact of atrial arrhythmias (AAs) or left atrial volume index (LAVI) on CSD outcome is unknown. To evaluate the impact of AAs and LAVI on CSD outcome and to assess changes in AAs burden and in atrial pacing after CSD METHODS: Patients with SHD undergoing CSD for VTs were analyzed. Hazard models were built to assess predictors of sustained VT/ICD shocks recurrences and death/orthotopic heart transplant (OHT). Changes before versus after CSD were assessed on ICD, clinical and echocardiographic data. A drug index was devised to correct for medication use. Between 2009 and 2018, 91 patients (56 ± 13 years, LVEF 34 ±14%, 47% with a history of AAs) underwent left (16%) or bilateral CSD (BCSD). The median FU was 14 months (IQR 4-37). Using multivariable analysis, neither LAVI nor AAs were associated with recurrences; LAVI was an independent predictor of death/OHT. AAs burden did not change after BCSD, but atrial pacing increased from a median of 28% to 72% (p <0.01). LV end-diastolic diameter slightly increased; however, sustained VT/ICD shocks were reduced. In patients with SHD undergoing CSD LAVI predicts death/OHT. AAs burden, already low at baseline, was unchanged after BCSD, while the need for atrial pacing increased, suggesting an impact of BCSD on sinus node chronotropism.